Position in CRDF
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$26,651
+$6,400 QoQ
Shares Held
20,501
+64.0% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 104 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PFG Investments, LLC holds $9,610,443 across 28 Biotechnology names. CRDF ranks #24 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ADMA |
Adma Biologics, Inc.
|
270,178 | $2,261,389 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,219 | $1,102,243 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
13,125 | $977,550 | |
| 4 | ARDX |
Ardelyx, Inc.
|
137,660 | $702,066 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
30,600 | $519,282 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
8,587 | $468,334 | |
| 7 | NGEN |
Nervgen Pharma Corp.
|
217,500 | $448,050 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
1,455 | $414,631 |
All Filings in CRDF
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,651 | 20,501 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $20,251 | 12,501 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $35,127 | 12,501 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $25,752 | 12,501 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $39,378 | 12,501 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $39,253 | 12,501 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $54,254 | 12,501 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $33,377 | 12,501 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $27,752 | 12,501 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $53,405 | 10,001 | Shares | Sole | 2024-04-22 | |
| No filing history on record for this holder in this stock. | ||||||